A woman has filed a breast cancer treatment side effects lawsuit against the manufacturers of Taxotere (docetaxel), Sanofi Aventis, alleging she suffered permanent and irreversible hair loss side effects.
Plaintiff Jennafer W. filed the breast cancer treatment side effects lawsuit in a federal court in California.
Jennafer says she suffered permanent hair loss after undergoing chemotherapy with Taxotere.
She also states that if she knew “that permanent hair loss could result, she would have selected a different treatment option …” Accusations against Sanofi made by Jennafer say the company failed and continues to fail in warning patients of permanent and irreversible hair loss side effects linked to Taxotere.
She claims neither she nor her healthcare providers were warned of possible disfiguring permanent hair loss that occurs following Taxotere treatment.
Jennafer demands a trial by jury.
Thousands of women have filed lawsuits against Taxotere’s manufacturer in a growing multidistrict litigation (MDL) against the company for adverse side effects they say they were never warned about, such as permanent and irreversible alopecia, also known as permanent hair loss.
Taxotere was approved by the FDA in 1996.
The Breast Cancer Treatment Side Effects Lawsuit is Case No.
3:18-cv-00738-MEJ, in the U.S. District Court for the Northern District of California.
A couple from Texas has filed a DePuy hip replacement symptoms lawsuit against DePuy Orthopaedics in a growing multidistrict litigation (MDL) against the company.
The Pinnacle hip implant MDL centers around allegations that the company concealed the defect of the hip replacement and misrepresented the medical device as safe and effective.
Plaintiffs Verlin B. and Judith B. filed their DePuy hip replacement symptoms lawsuit on Feb. 7, 2018 in federal court in Texas.
Verlin says that he underwent a left total hip arthroplasty procedure on Sept. 16, 2010, where he was implanted with a Pinnacle device with a metal liner.
Verlin states that had DePuy “not concealed the known defects, the early failure rate, the known complications and the unreasonable risks associated with the use of the Pinnacle Device, … [he] would not have consented to the Pinnacle Device being used in his total hip arthroplasty.” The DePuy hip replacement symptoms lawsuit alleges multiple counts including negligence, failure to warn, manufacturing defect, design defect, negligent misrepresentation, breach of express warranty, breach of implied warranty against the implant manufacturer.
However, the allegedly defective MoM device causes serious injuries including pain, bone loss, and the release of toxic levels of metal particles into the bloodstream.
Another adverse effect is the deposit and build-up of metal debris in the body’s soft tissues, known as metallosis.
The following have been reported among other potential DePuy Pinnacle hip replacement issues: • Difficulty weight bearing • Trouble standing or walking • Hip pain • The loosening of the Pinnacle Hip Device • Requirement for revision hip replacement surgery • Metallosis (metal poisoning) These adverse effects are said to happen when the MoM device is used in combination with a metal acetabular liner called Ultamet.
In fact, the U.S. Food and Drug Administration (FDA) have received nearly 1,300 adverse event reports of patients experiencing complications and injuries, and those experiencing these adverse effects may have legal recourse in the filing of a DePuy hip replacement symptoms lawsuit.
The DePuy Hip Replacement Symptoms Lawsuit is Case No.
This plate is implanted into the tibia bone without the use of cement.
This is to give the implant stability without the use of cement, as with previous knee implant systems.
According to the FDA announcement, “Zimmer, Inc. is initiating a voluntary recall of Persona Trabecular Metal Tibial following an increase in complaints of radiolucent lines and loosening.
The tibial plate of the Zimmer Persona knee implant has been connected with a few serious issues: radiolucent lines and loosening.
Radiolucent lines show up on X-rays and can indicate future device failure.
Many patients and doctors have reported radiolucent lines with Zimmer Persona knee implant devices.
Second, there have been many reports of device loosening.
A joint replacement should last between ten and twenty years, but early loosening can be a sign of future device failure.
Zimmer Persona knee implant patients who experience early device loosening are also likely candidates for revision surgery.
Revision surgery is costly and is often riskier than the original surgery to implant the device.
Plaintiff Mervin C. chose to file the Bair Hugger lawsuit after discovering the manufacturing companies either knew or should have known about the alleged correlation between the Bair Hugger device and deep joint infections.
According to the Bair Hugger lawsuit, Mervin underwent surgery on June 6, 2012 in which the warming blanket device was used.
Following surgery, he developed a deep joint infection.
A few months later, Mervin needed further hospital care to have his left hip implant reimplanted.
Mervin alleges the infection in his hip was caused by the Bair Hugger used in his surgery, and he opted to file the Bair Hugger lawsuit after learning other patients had similar experiences.
Mervin’s Bair Hugger lawsuit is being filed in MDL No.
Mervin is filing this Bair Hugger lawsuit raising claims of negligence and failure to warn.
Mervin states that at no point in time did 3M or Arizant warn him or his physician about potential bacterial infection developing on joints in conjunction with the Bair Hugger warming blanket.
This Bair Hugger Lawsuit is Case No.
In general, Bair Hugger lawsuits are filed individually by each plaintiff and are not class actions.
The blood thinning drug Pradaxa was the first medication to be approved for anticoagulant treatment purposes since warfarin in the 1950s.
When Pradaxa first entered the market in 2010, it was touted as superior to warfarin for its efficacy and convenience.
While warfarin patients have the readily available vitamin K in case this happens, Pradaxa patients only recently got an approved bleeding antidote approved.
While Boehringer Ingelheim did successfully release a reversal agent for the blood thinning drug Pradaxa, the company allegedly failed to warn patients against potentially fatal internal bleeding.
According to the Institute for Safe Medication Practices (ISMP), over 307 injury reports were submitted to the FDA during the first three months the blood thinning drug Pradaxa was on the market.
While the FDA did note that potential uncontrollable internal bleeding was a risk with all anticoagulants, the FDA stated it was investigating whether or not Pradaxa carried a higher risk.
Even though potentially uncontrollable internal bleeding can be fatal, Boehringer Ingelheim allegedly failed to warn patients against this risk.
Numerous patients who suffered complications relating to the blood thinning drug Pradaxa have filed legal action against the company, with Boehringer Ingelheim already paying out millions in settlements.
In general, Pradaxa lawsuits are filed individually by each plaintiff and are not class actions.
Fill out the form on this page now for a free, immediate, and confidential case evaluation.
A Pennsylvania couple has filed an IVC blood clot filter lawsuit against Cook Medical claiming that wife’s IVC filter was defective.
Plaintiffs Niculina C. and Mihai C. have filed this IVC blood clot filter lawsuit after Niculina was implanted with the Gunther Tulip Vena Cava Filter in February 2007.
She claims she experienced unexpected complications thereafter.
This IVC Blood Clot Filter Lawsuit is Case No.
An IVC blood clot filter is a tiny device shaped somewhat like a collapsible umbrella that is placed within the inferior vena cava in order to catch blood clots in a person that is prone to developing them.
A blood clot that forms in the lower extremity can loosen from where it has formed and travel throughout the body.
Even though an IVC blood clot filter can be permanent or temporary, it is recommended that an IVC blood clot filter be removed as soon as the danger for blood clots has passed to avoid exposing the patient to an unnecessary risk of IVC filter complications.
Many patients who have received an IVC blood clot filter have suffered dangerous complications.
Cook is not the only IVC blood clot filter manufacturer that has had problems with their devices.
It is important to note that even if an individual has not experienced complications with their blood clot filter, they may be able to file an IVC blood clot filter lawsuit.
Unfortunately, Terry D. was diagnosed with malignant melanoma on March 18, 2014, and died on Jan. 4, 2015.
Charlotte alleges there is a serious risk of melanoma connected with erectile dysfunction drugs like Viagra, and that Pfizer was aware of this risk.
This Viagra lawsuit was filed on 16 separate counts, including defective design, failure to warn, gross negligence, and fraudulent misrepresentation and concealment.
Viagra is prescribed to men to treat erectile dysfunction.
Originally developed as a treatment for high blood pressure, Viagra inhibits the secretion of a certain enzyme, allowing the blood to flow more freely.
Viagra has become almost a household name, and is the most popular erectile dysfunction drug by far.
Viagra accounts for nearly half of the U.S. sale of erectile dysfunction drugs.
The other, less likely to be fatal skin cancers are basal cell and squamous cell.
If you or someone you love has been diagnosed with Viagra melanoma skin cancer after using either Viagra or a similar erectile dysfunction drug, you may be able to file a Viagra lawsuit.
3:16-cv-03417, in the U.S. District Court for the San Francisco Division of the Northern District of California.
Despite the popularity of the epilepsy medication Dilantin, the drug has unfortunately been linked with some serious and permanent side effects, including cerebellar degeneration.
During an epileptic seizure, a person’s brain fires neurons much more rapidly than normal, which can cause symptoms like uncontrollable movements.
Despite the undeniable popularity, the drug has unfortunately been linked with serious neurological side effects, including cerebellar degeneration.
As the brain gradually loses neurons, it also gradually loses some of the functions of the cerebellum—and this part of the brain is in charge of several functions essential to daily life.
A study of Dilantin’s neurological side effects, published in the Seizure European Journal of Epilepsy, found that cerebellar degeneration was linked with the use of Dilantin.
While a long-term Dilantin patient or a patient taking a higher dosage of the drug is more likely to suffer cerebellar degeneration, it is still possible for patients who have used the drug for a shorter period of time and at a lower dosage to suffer as well.
For some, treating cerebellar degeneration can be very simple, only requiring that the patient stop taking Dilantin.
Patients may continue to suffer severe side effects indefinitely.
If you or someone you love has suffered from cerebellar degeneration after using Dilantin, you may be able to file a lawsuit.
In general, phenytoin lawsuits are filed individually by each plaintiff and are not class actions.
A Texas man recently filed a lawsuit against the manufacturers of the drug Abilify, alleging that the drug caused compulsive behavior.
This February, plaintiff Emerson R. filed a suit against Abilify manufacturers and distributors as part of a multi-district litigation, raising allegations of Abilify linked to compulsive behavior.
Abilify is an anti-psychotic medication commonly prescribed for depression, bipolar disorder, and schizophrenia.
Emerson’s suit follows numerous other legal complaints claiming Abilify is linked to compulsive behavior.
The suit cites a series of scientific case studies that allegedly show Abilify linked to compulsive behavior based on dopamine reactions.
In 2015, Canadian regulators allegedly found Abilify linked to compulsive behaviors and required a warning for such risks to be included.
“Despite these warnings and advisories in Europe and Canada—for the same drug sold to patients in the United States—the labeling for Abilify in the United States did not adequately warn about the risk of compulsive gambling and contained no mention that pathological gambling had been reported in patients prescribed Abilify.” In 2016, Abilify allegedly added pathological gambling to the post-market experience section of the label.
The lawsuit also claims that Abilify manufacturers made no attempt to warn doctors and consumers of compulsive behavior risks before 2016.
The Abilify Compulsive Behavior Lawsuit is Case No.
In general, Rexulti and Abilify lawsuits are filed individually by each plaintiff and are not class actions.
A Tennessee man has filed a new lawsuit against Ethicon, alleging he suffered from serious abdominal hernia mesh complications because of the company’s medical device.
The plaintiff, Robert K., was implanted with an Ethicon abdominal hernia mesh device on Oct. 6, 2015.
Robert filed his hernia mesh lawsuit against Ethicon and its parent company, pharmaceutical giant Johnson & Johnson, alleging his abdominal hernia mesh complications were a direct result of the company’s failure to give adequate warning.
Robert filed the lawsuit on Jan. 27, 2018 in the U.S. District Court for the Atlanta Division of the Northern District of Georgia.
Though hernia mesh devices are widely used, a growing number of patients implanted with hernia mesh are reporting serious abdominal hernia mesh complications associated with their implants.
Robert is far from the first patient implanted with a hernia mesh device to suffer from abdominal hernia mesh complications.
Some abdominal hernia mesh complications have even required patients to undergo revision surgery.
If you or someone you love has suffered from abdominal hernia mesh complications after undergoing hernia repair, even months or years after the fact, you may be able to file a hernia mesh lawsuit.
While filing a lawsuit cannot take away the pain and suffering caused by these side effects, it can help to alleviate the financial burden caused by medical expenses and lost wages.
The Abdominal Hernia Mesh Complications Lawsuit is Case No.